During the past decade, UCLA Women's Health Clinical Research Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Women's Health Clinical Research Unit" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Women's Health Clinical Research Unit" are "Complete Response" (1 trials), "Epithelial Ovarian Cancer" (1 trials), "FIGO Stage III-IV" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Newly Diagnosed" (1 trials). Many other conditions were trialed in "UCLA Women's Health Clinical Research Unit" in a lesser frequency.

Most popular intervention types in "UCLA Women's Health Clinical Research Unit" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Batiraxcept" (1 trials), "Nivolumab" (1 trials), "Paclitaxel" (1 trials), "Placebo" (1 trials) and "Placebo IV Infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Women's Health Clinical Research Unit" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "UCLA Women's Health Clinical Research Unit". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UCLA Women's Health Clinical Research Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Women's Health Clinical Research Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".